My studies are focused on the liver and in different alterations in the organism during cirrhosis and chronic liver diseases, especially vascular dysfunction, endothelial-to-mesenchymal transition, lymphatic dysfunction and angiogenesis. In the recent years, I have also developed studies based on nanotechnology, hepatic regeneration in mice, microRNAs (miR-122), cancer, metastases, RNA helicases and targets of AKT (DHX15, TCF20).
My studies are focused on the liver and in different alterations in the organism during cirrhosis and chronic liver diseases, especially vascular dysfunction, endothelial-to-mesenchymal transition, lymphatic dysfunction and angiogenesis. In the recent years, I have also developed studies based on nanotechnology, hepatic regeneration in mice, microRNAs (miR-122), cancer, metastases, RNA helicases and targets of AKT (DHX15, TCF20).